Using GIS and Remote Sensing to build Master Sampling Frames for Agricultural Statistics

This report is a JRC contribution to the FAO Global Strategy to improve Agricultural and Rural Statistics (GSARS). Its aim is providing guidelines on the suitable ways to use satellite images and geographic information tools to build master sampling frames that can be used both for agricultural and environmental statistics. The main readers to which the report is addressed are agricultural and environmental statisticians in developing countries. We consider separately the use of technological tools for area sampling frames and for list sampling frames. The use of Global Navigation Satellite Systems (GNSS), better known as GPS, is also discussed, although its use is more connected to carrying out field surveys rather than to the design of sampling frames.JRC.H.4-Monitoring Agricultural Resource

Analysis of Factors and Medical Errors Involved in Patient Complaints in a European Emergency Department

Introduction: Patients’ complaints from Emergency Departments (ED) are frequent and can be used as a quality assurance indicator. Objective: Factors contributing to patients’ complaints (PCs) in the emergency department were analyzed.  Methods: It was a retrospective cohort study, the qualitative variables of patients’ complaints visiting ED of a university hospital were compared with Chi-Square and t test tests. Results: Eighty-five PC were analyzed. The factors contributing to PC were: communication (n=26), length of stay (LOS) (n=24), diagnostic errors (n=21), comfort and privacy issues (n=7), pain management (n=6), inappropriate treatment (n=6), delay of care and billing issues (n=3). PCs were more frequent when patients were managed by residents, during night shifts, weekends, Saturdays, Mondays, January and June. Moreover, the factors contributing to diagnostic errors were due to poor communication, non-adherence to guidelines and lack of systematic proofreading of X-rays. In 98% of cases, disputes were resolved by apology and explanation and three cases resulted in financial compensation. Conclusion: Poor communication, LOS and medical errors are factors contributing to PCs. Improving communication, resolving issues leading to slow health care provision, adequate staffing and supervision of trainees may reduce PCs

Analysis of Factors and Medical Errors Involved in Patient Complaints in a European Emergency Department

Introduction: Patients’ complaints from Emergency Departments (ED) are frequent and can be used as a quality assurance indicator. Objective: Factors contributing to patients’ complaints (PCs) in the emergency department were analyzed.  Methods: It was a retrospective cohort study, the qualitative variables of patients’ complaints visiting ED of a university hospital were compared with Chi-Square and t test tests. Results: Eighty-five PC were analyzed. The factors contributing to PC were: communication (n=26), length of stay (LOS) (n=24), diagnostic errors (n=21), comfort and privacy issues (n=7), pain management (n=6), inappropriate treatment (n=6), delay of care and billing issues (n=3). PCs were more frequent when patients were managed by residents, during night shifts, weekends, Saturdays, Mondays, January and June. Moreover, the factors contributing to diagnostic errors were due to poor communication, non-adherence to guidelines and lack of systematic proofreading of X-rays. In 98% of cases, disputes were resolved by apology and explanation and three cases resulted in financial compensation. Conclusion: Poor communication, LOS and medical errors are factors contributing to PCs. Improving communication, resolving issues leading to slow health care provision, adequate staffing and supervision of trainees may reduce PCs

Rôle de la niche mésenchymateuse dans la régulation du phénotype SP des progéniteurs hématopoïétiques humains

L hématopoïèse est un processus finement régulé pour permettre sa pérennité et son adaptation aux contraintes physiologiques et pathologiques. Ce potentiel repose en grande partie sur les capacités de quiescence, auto-renouvellement, division asymétrique et multipotence des cellules souches hématopoïétiques (CSH). Les CSH et progéniteurs hématopoïétiques (CSPH) sont principalement régulés de façon extrinsèque au sein des niches hématopoïétiques médullaires et cette régulation fait intervenir, des contacts intercellulaires et des facteurs diffusibles. Le phénotype side-population (SP), secondaire à l efflux actif d un colorant fluorescent (Hoechst 33342) par des pompes de type multidrugresistance, est une caractéristique des cellules souches de la plupart des tissus. Au sein de l hématopoïèse, le phénotype SP est un excellent moyen pour identifier les CSH murines et est associé à leur quiescence et à leur adhésion à la niche endostéale, mais sa valeur comme marqueur des CSH est plus discutée chez l homme. Les cellules SP, de par leur nature, sont également étudiées en oncologie, et sont associées aux cellules tumorales les plus résistantes et les plus tumorogènes. La compréhension des mécanismes régulant la fonctionnalité SP devrait permettre d ouvrir des pistes en physiologie quand à la compréhension de la régulation des CSPH par les niches mésenchymateuses et en pathologie pour cibler les mécanismes de chimiorésistance.Dans ce travail nous montrons pour la première fois chez l homme que l acquisition du phénotype SP est un phénomène dynamique et versatile sous le contrôle du stroma médullaire. Le stroma médullaire est en effet capable de maintenir le phénotype SP de CSPH médullaires et d induire le phénotype SP de CSPH circulants. L acquisition du phénotype SP par les cellules circulantes nécessite à la fois un nichage au sein du stroma et des facteurs diffusibles. Les cellules circulantes capables d acquérir le phénotype SP contiennent des CSPH au regard de (i) leur expression du CD34, (ii) leur richesse en cellules quiescentes, (iii) leur capacité clonogénique et proliférative en cultures secondaires, (iv) leur expression des gènes de nichage et de souchitude , (v) leur capacité de migration en réponse à un gradient de CXCL12, (vi) leur activité LT-SRC in vivo. De plus nous avons mis en évidence, au sein de ces CSPH SP+CD34+ révélés par le stroma médullaire, une sous-population CD44-/faible qui pourrait contenir les cellules plus immatures en raison de sa quiescence et de l intensité de son efflux du Hoechst 33342. Les études mécanistiques montrent que l acquisition du phénotype SP par les cellules circulantes est sous la dépendance de l intégrine VLA-4 et du CD44. La transduction du signal implique des protéines G et la famille des Src-kinases. Nous montrons également que le stroma médullaire peut induire/maintenir/amplifier la fonctionnalité SP de blastes circulants de leucémie aigüe myéloblastique de façon ß1-intégrine dépendante et que cette fonctionnalité est associée à une capacité d efflux de Mitoxantrone. Ce mécanisme de modulation de l activité d ABC-transporteurs par l adhésion au stroma correspond à un mécanisme encore jamais décrit de CAM-DR.Hematopoiesis is a finely tuned process to allow its long-term efficiency and its adaptation to various physiological and pathological stresses. Hematopoietic stem cell (HSC) is the keystone of hematopoiesis through its multipotency, quiescence, asymmetrical division and self-renewing properties. HSC bone marrow (BM) niches mainly regulate hematopoietic stem and progenitor cells (HSPC) through intercellular contacts and diffusible factors. Side-population (SP) cells are characterized by their capability to actively efflux Hoechst 33342 dye through multidrug resistance-like pumps. SP phenotype is a characteristic of stem cells in many tissues and especially, it is a stringent criterion to purify murine HSCs. In mice, this phenotype has been demonstrated to be related to quiescence and resistance to drugs/environmental stresses and to be controlled by endosteal niche adhesion. SP cells are also studied in oncology and are associated to chemo-resistance and tumor initiating capacity. At steady state, SP cells are mainly present in the BM and are mostly absent from the circulation except in stress conditions, raising the hypothesis of the versatility of the SP functionality. Therefore, studying SP phenotype regulation is of importance to understand how BM niches regulate HSPC and how to interfere with cancer cells chemo-resistance.In this work, we demonstrate for the first time and in human that SP phenotype acquisition is a dynamic phenomenon under control of stromal BM cells. Stromal cells from healthy donors maintain SP phenotype of BM HSPC and promote SP phenotype acquisition in circulating ones. SP phenotype promotion depends of stroma nesting and of diffusible factors secretion. This stroma-induced circulating SP cell fraction contains HSPC, as ascertained by (i) CD34 expression, (ii) proportion of cells in G0, (iii) clonogenic and proliferative potential, (iv) nesting and stemness gene expression, (v) CXCL12-related migration capability and (vi) LT-SRC activity. Moreover, we describe an SP+CD34+CD44-/low sub-population that could contain most immature HSPCs with regards to their quiescence and Hoechst efflux intensity. Mechanistic studies show that the stoma-mediated SP promoting effect is VLA-4/ 4ß1-integrin and CD44 dependent, and implicate G-protein and Src-kinase pathways. We also demonstrate that BM stroma from healthy donors can induce/maintain/amplify in a ß1-integrin dependent manner an SP sub-population with mitoxantrone efflux capability in blast cells from acute myeloid leukemia. The existence of a similar mechanism in circulating leukemic blasts suggests the possibility to interfere with the chemo-resistant phenotype of blast cells through integrin/CD44 axis blockade.PARIS11-SCD-Bib. électronique (914719901) / SudocSudocFranceF

Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism

SummaryIn cytotoxic T cells (CTL), Akt, also known as protein kinase B, is activated by the T cell antigen receptor (TCR) and the cytokine interleukin 2 (IL-2). Akt can control cell metabolism in many cell types but whether this role is important for CTL function has not been determined. Here we have shown that Akt does not mediate IL-2- or TCR-induced cell metabolic responses; rather, this role is assumed by other Akt-related kinases. There is, however, a nonredundant role for sustained and strong activation of Akt in CTL to coordinate the TCR- and IL-2-induced transcriptional programs that control expression of key cytolytic effector molecules, adhesion molecules, and cytokine and chemokine receptors that distinguish effector versus memory and naive T cells. Akt is thus dispensable for metabolism, but the strength and duration of Akt activity dictates the CTL transcriptional program and determines CTL fate

Waveguide optical parametric amplifiers in silicon nitride with 2D graphene oxide films

Optical parametric amplification (OPA) represents a powerful solution to achieve broadband amplification in wavelength ranges beyond the scope of conventional gain media, for generating high-power optical pulses, optical microcombs, entangled photon pairs and a wide range of other applications. Here, we demonstrate optical parametric amplifiers based on silicon nitride (Si3N4) waveguides integrated with two-dimensional (2D) layered graphene oxide (GO) films. We achieve precise control over the thickness, length, and position of the GO films using a transfer-free, layer-by-layer coating method combined with accurate window opening in the chip cladding using photolithography. Detailed OPA measurements with a pulsed pump for the fabricated devices with different GO film thicknesses and lengths show a maximum parametric gain of ~24.0 dB, representing a ~12.2 dB improvement relative to the device without GO. We perform a theoretical analysis of the device performance, achieving good agreement with experiment and showing that there is substantial room for further improvement. This work represents the first demonstration of integrating 2D materials on chips to enhance the OPA performance, providing a new way of achieving high performance photonic integrated OPA by incorporating 2D materials.Comment: 38 pages, 8 figures, 80 reference

Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes

In normal T cell progenitors, phosphoinositide-dependent kinase l (PDK1)–mediated phosphorylation and activation of protein kinase B (PKB) is essential for the phosphorylation and inactivation of Foxo family transcription factors, and also controls T cell growth and proliferation. The current study has characterized the role of PDK1 in the pathology caused by deletion of the tumor suppressor phosphatase and tensin homologue deleted on chromosome 10 (PTEN). PDK1 is shown to be essential for lymphomagenesis caused by deletion of PTEN in T cell progenitors. However, PTEN deletion bypasses the normal PDK1-controlled signaling pathways that determine thymocyte growth and proliferation. PDK1 does have important functions in PTEN-null thymocytes, notably to control the PKB–Foxo signaling axis and to direct the repertoire of adhesion and chemokine receptors expressed by PTEN-null T cells. The results thus provide two novel insights concerning pathological signaling caused by PTEN loss in lymphocytes. First, PTEN deletion bypasses the normal PDK1-controlled metabolic checkpoints that determine cell growth and proliferation. Second, PDK1 determines the cohort of chemokine and adhesion receptors expressed by PTEN-null cells, thereby controlling their migratory capacity

Resting natural killer cell homeostasis relies on tryptophan/NAD+^{+} metabolism and HIF-1α

Natural killer (NK) cells are forced to cope with different oxygen environments even under resting conditions. The adaptation to low oxygen is regulated by oxygen-sensitive transcription factors, the hypoxia-inducible factors (HIFs). The function of HIFs for NK cell activation and metabolic rewiring remains controversial. Activated NK cells are predominantly glycolytic, but the metabolic programs that ensure the maintenance of resting NK cells are enigmatic. By combining in situ metabolomic and transcriptomic analyses in resting murine NK cells, our study defines HIF-1α as a regulator of tryptophan metabolism and cellular nicotinamide adenine dinucleotide (NAD$^{+}$ ) levels. The HIF-1α/NAD$^{+}$ axis prevents ROS production during oxidative phosphorylation (OxPhos) and thereby blocks DNA damage and NK cell apoptosis under steady-state conditions. In contrast, in activated NK cells under hypoxia, HIF-1α is required for glycolysis, and forced HIF-1α expression boosts glycolysis and NK cell performance in vitro and in vivo. Our data highlight two distinct pathways by which HIF-1α interferes with NK cell metabolism. While HIF-1α-driven glycolysis is essential for NK cell activation, resting NK cell homeostasis relies on HIF-1α-dependent tryptophan/NAD$^{+}$ metabolism

Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis

Primary myelofibrosis is characterized by clonal myeloproliferation, dysmegakaryopoiesis, extramedullary hematopoiesis associated with myelofibrosis and altered stroma in the bone marrow and spleen. The expression of CD9, a tetraspanin known to participate in megakaryopoiesis, platelet formation, cell migration and interaction with stroma, is deregulated in patients with primary myelofibrosis and is correlated with stage of myelofibrosis. We investigated whether CD9 participates in the dysmegakaryopoiesis observed in patients and whether it is involved in the altered interplay between megakaryocytes and stromal cells. We found that CD9 expression was modulated during megakaryocyte differentiation in primary myelofibrosis and that cell surface CD9 engagement by antibody ligation improved the dysmegakaryopoiesis by restoring the balance of MAPK and PI3K signaling. When co-cultured on bone marrow mesenchymal stromal cells from patients, megakaryocytes from patients with primary myelofibrosis displayed modified behaviors in terms of adhesion, cell survival and proliferation as compared to megakaryocytes from healthy donors. These modifications were reversed after antibody ligation of cell surface CD9, suggesting the participation of CD9 in the abnormal interplay between primary myelofibrosis megakaryocytes and stroma. Furthermore, silencing of CD9 reduced CXCL12 and CXCR4 expression in primary myelofibrosis megakaryocytes as well as their CXCL12-dependent migration. Collectively, our results indicate that CD9 plays a role in the dysmegakaryopoiesis that occurs in primary myelofibrosis and affects interactions between megakaryocytes and bone marrow stromal cells. These results strengthen the “bad seed in bad soil” hypothesis that we have previously proposed, in which alterations of reciprocal interactions between hematopoietic and stromal cells participate in the pathogenesis of primary myelofibrosis